GB1533464A - Cancer diagnostic agents - Google Patents

Cancer diagnostic agents

Info

Publication number
GB1533464A
GB1533464A GB6357/76A GB635776A GB1533464A GB 1533464 A GB1533464 A GB 1533464A GB 6357/76 A GB6357/76 A GB 6357/76A GB 635776 A GB635776 A GB 635776A GB 1533464 A GB1533464 A GB 1533464A
Authority
GB
United Kingdom
Prior art keywords
recognin
dissolved
solubilised
tissue
recognins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6357/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1533464A publication Critical patent/GB1533464A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
GB6357/76A 1975-02-18 1975-10-15 Cancer diagnostic agents Expired GB1533464A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55043275A 1975-02-18 1975-02-18
US55307575A 1975-02-25 1975-02-25
US62111275A 1975-10-09 1975-10-09

Publications (1)

Publication Number Publication Date
GB1533464A true GB1533464A (en) 1978-11-22

Family

ID=27415588

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6357/76A Expired GB1533464A (en) 1975-02-18 1975-10-15 Cancer diagnostic agents

Country Status (4)

Country Link
JP (2) JPH0146520B2 (enExample)
CH (1) CH639102A5 (enExample)
DE (1) DE2606257A1 (enExample)
GB (1) GB1533464A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015755A3 (en) * 1979-03-09 1980-12-10 Samuel Dr. Bogoch Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007214B1 (en) * 1978-07-07 1985-10-23 Samuel Dr. Bogoch Product for detecting the presence of cancerous or malignant tumor cells
GB2043890B (en) * 1979-01-30 1983-09-07 Otsuka Pharma Co Ltd Determination of tumour associated glycolinkage and diagnosis of cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0015755A3 (en) * 1979-03-09 1980-12-10 Samuel Dr. Bogoch Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors

Also Published As

Publication number Publication date
CH639102A5 (en) 1983-10-31
DE2606257A1 (de) 1976-08-26
JPS51108001A (enExample) 1976-09-25
JPH0257671B2 (enExample) 1990-12-05
JPH0146520B2 (enExample) 1989-10-09
JPH01112163A (ja) 1989-04-28

Similar Documents

Publication Publication Date Title
Astwood et al. Two metabolically active peptides from porcine pituitary glands
ZA76339B (en) Process for preparing soy protein concentrate
GB1331011A (en) 1,25-dihydroxycholecalciferol and process for preparing same
NL7610139A (nl) Werkwijze voor het bereiden van antracycline- -glycosidepreparaten.
YU41776A (en) Process for obtaining protein concentrates suitable as foodstuffs by separation of phenol and oligosaccharides from vegetable tissues
Hendler Some properties and the possible metabolic significance of amino acid-lipid complexes
NL7609415A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van nieuwe thiazolinyl- en thiazinylbenzimida- zoolverbindingen.
Swager et al. Coumarins from Musineon divaricatum
Cardellina Step gradient elution in gel permeation chromatography. A new approach to natural products separations
EP0216936A4 (en) NEW COMPOSITION BASED ON TANNIN.
Tursch et al. Two novel alkaloids from american ladybug Hippodamia-convergens (coleoptera, coccinellidae)
ES437046A2 (es) Un procedimiento para la preparacion de un concentrado o mezcla de hormonas.
NL7711916A (nl) Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
Vanderhaeghe et al. Identity of ramycin with fusidic acid
OKUDAIRA et al. Cytotoxic factor demonstrated in lymph node extract
Miccio et al. Bilitranslocase is the protein responsible for the electrogenic movement of sulfobromophthalein in plasma membrane vesicles from rat liver: immunochemical evidence using mono-and poly-clonal antibodies
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
Thomson et al. Tenebrosin-A, a new cardiostimulant protein from the Australian sea anemone Actinia tenebrosa
NL7607693A (nl) Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten.
OHASHI et al. Purification of toxohormone by DEAE-cellulose columnchromatography
ES388011A1 (es) Procedimiento para la obtencion de polvos de recubrimiento pigmentado.
Angeletti et al. Chromatography of Proteins of Squamous Cell Carcinomas and Normal Epithelium of Mice.
Helmy et al. An ethanolamine plasmalogen artifact formed by acetone extraction of freeze-dried tissue
SE8205282L (sv) Samtidiga extraktioner av lipider och polyfenoler fran solrosfron i flingform
DE2967143D1 (en) Diagnostic method, especially for the early recognition of malignant tumors and/or viral diseases, and means to carry it out

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee
728C Application made for restoration (sect. 28/1977)
728A Order made restoring the patent (sect. 28/1977)
PCNP Patent ceased through non-payment of renewal fee